Nebulized and intranasal fentanyl in the management of cancer-related breakthrough pain.
Zeppetella
G
G
St Joseph's Hospice, Royal Hospitals NHS Trust, London, UK. jzeppetella@stjosephshospice.org.uk
D000280:Administration, Inhalation; D000281:Administration, Intranasal; D000368:Aged; D000369:Aged, 80 and over; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D005283:Fentanyl / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy*; D010146:Pain / Q000188:drug therapy* / Q000209:etiology; D010147:Pain Measurement
D000701:Analgesics, Opioid; D000970:Antineoplastic Agents; D005283:Fentanyl